Cerebral microbleeds with posterior reversible encephalopathy syndrome

A rare complication in acute lymphoblastic leukaemia

Aravind Yogabalan, Karthick Udupa

Research output: Contribution to journalArticle

Abstract

Cerebral microbleeds are a rare entity usually seen in hypertensive microangiopathy or amyloid angiopathy. Its occurrence in Acute Lymphoblastic Leukaemia (ALL) has not been reported so far. Clinicians while treating patients should be aware of such complications for timely diagnosis and management. This is a case report on 19-year-old male, who was on treatment for ALL, under induction phase of the Berlin-Frankfurt-Munster-95 (BFM-95) regimen, who developed one episode of generalised tonic-clonic seizures. The MRI brain in T2 sequence showed hyperintense lesions in the white matter of occipital region, suggestive of Posterior Reversible Encephalopathy Syndrome (PRES). Susceptibility Weighted Imaging (SWI) showed multifocal areas of blooming in bilateral cerebral hemispheres suggestive of microbleeds. The fibrinogen level was very low strongly suggestive of L-Asparaginase induced microbleeds. The patient was treated with antiepileptic and cryoprecipitate transfusion to maintain fibrinogen levels and further doses of L-Asparaginase were withheld. He recovered without any neurological sequelae.

Original languageEnglish
Pages (from-to)XD01-XD02
JournalJournal of Clinical and Diagnostic Research
Volume12
Issue number4
DOIs
Publication statusPublished - 01-04-2018
Externally publishedYes

Fingerprint

Posterior Leukoencephalopathy Syndrome
Asparaginase
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Fibrinogen
Occipital Lobe
Cerebrum
Berlin
Amyloid
Anticonvulsants
Magnetic resonance imaging
Brain
Seizures
Imaging techniques
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{875653ee700b4f0a83318e1900fb2467,
title = "Cerebral microbleeds with posterior reversible encephalopathy syndrome: A rare complication in acute lymphoblastic leukaemia",
abstract = "Cerebral microbleeds are a rare entity usually seen in hypertensive microangiopathy or amyloid angiopathy. Its occurrence in Acute Lymphoblastic Leukaemia (ALL) has not been reported so far. Clinicians while treating patients should be aware of such complications for timely diagnosis and management. This is a case report on 19-year-old male, who was on treatment for ALL, under induction phase of the Berlin-Frankfurt-Munster-95 (BFM-95) regimen, who developed one episode of generalised tonic-clonic seizures. The MRI brain in T2 sequence showed hyperintense lesions in the white matter of occipital region, suggestive of Posterior Reversible Encephalopathy Syndrome (PRES). Susceptibility Weighted Imaging (SWI) showed multifocal areas of blooming in bilateral cerebral hemispheres suggestive of microbleeds. The fibrinogen level was very low strongly suggestive of L-Asparaginase induced microbleeds. The patient was treated with antiepileptic and cryoprecipitate transfusion to maintain fibrinogen levels and further doses of L-Asparaginase were withheld. He recovered without any neurological sequelae.",
author = "Aravind Yogabalan and Karthick Udupa",
year = "2018",
month = "4",
day = "1",
doi = "10.7860/JCDR/2018/34499.11371",
language = "English",
volume = "12",
pages = "XD01--XD02",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "4",

}

Cerebral microbleeds with posterior reversible encephalopathy syndrome : A rare complication in acute lymphoblastic leukaemia. / Yogabalan, Aravind; Udupa, Karthick.

In: Journal of Clinical and Diagnostic Research, Vol. 12, No. 4, 01.04.2018, p. XD01-XD02.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cerebral microbleeds with posterior reversible encephalopathy syndrome

T2 - A rare complication in acute lymphoblastic leukaemia

AU - Yogabalan, Aravind

AU - Udupa, Karthick

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Cerebral microbleeds are a rare entity usually seen in hypertensive microangiopathy or amyloid angiopathy. Its occurrence in Acute Lymphoblastic Leukaemia (ALL) has not been reported so far. Clinicians while treating patients should be aware of such complications for timely diagnosis and management. This is a case report on 19-year-old male, who was on treatment for ALL, under induction phase of the Berlin-Frankfurt-Munster-95 (BFM-95) regimen, who developed one episode of generalised tonic-clonic seizures. The MRI brain in T2 sequence showed hyperintense lesions in the white matter of occipital region, suggestive of Posterior Reversible Encephalopathy Syndrome (PRES). Susceptibility Weighted Imaging (SWI) showed multifocal areas of blooming in bilateral cerebral hemispheres suggestive of microbleeds. The fibrinogen level was very low strongly suggestive of L-Asparaginase induced microbleeds. The patient was treated with antiepileptic and cryoprecipitate transfusion to maintain fibrinogen levels and further doses of L-Asparaginase were withheld. He recovered without any neurological sequelae.

AB - Cerebral microbleeds are a rare entity usually seen in hypertensive microangiopathy or amyloid angiopathy. Its occurrence in Acute Lymphoblastic Leukaemia (ALL) has not been reported so far. Clinicians while treating patients should be aware of such complications for timely diagnosis and management. This is a case report on 19-year-old male, who was on treatment for ALL, under induction phase of the Berlin-Frankfurt-Munster-95 (BFM-95) regimen, who developed one episode of generalised tonic-clonic seizures. The MRI brain in T2 sequence showed hyperintense lesions in the white matter of occipital region, suggestive of Posterior Reversible Encephalopathy Syndrome (PRES). Susceptibility Weighted Imaging (SWI) showed multifocal areas of blooming in bilateral cerebral hemispheres suggestive of microbleeds. The fibrinogen level was very low strongly suggestive of L-Asparaginase induced microbleeds. The patient was treated with antiepileptic and cryoprecipitate transfusion to maintain fibrinogen levels and further doses of L-Asparaginase were withheld. He recovered without any neurological sequelae.

UR - http://www.scopus.com/inward/record.url?scp=85045332915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045332915&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2018/34499.11371

DO - 10.7860/JCDR/2018/34499.11371

M3 - Article

VL - 12

SP - XD01-XD02

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 4

ER -